Psoriatic arthritis trials in Czechia
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 4RecruitingResearch participation
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
- Where
- Brno, Brno-Židenice, Hlučín, Novy Hradec Kralove, Olomouc, Prague, Prague 1, Prague 11, Prague 2, Prague 4, Praha 4, Trebovice, Uherské Hradiště
- People
- 339 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04638647EU 2023-504417-67-00Registry updated 2026-11-09
Phase 2RecruitingTrial-stage medicine
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Where
- Brno, Hlučín, Uherské Hradiště, Zlín
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- AbbVie
See details and how to joinNCT06865105Registry updated 2026-11-09
Phase 1RecruitingTrial-stage medicine
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Where
- Brno, Hlučín, Ostrava, Uherské Hradiště
- Age
- 18 years and over
- People
- 392 worldwide
- Run by
- UCB Biopharma SRL
See details and how to joinNCT07290036Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Brno, Prague
- Age
- 1 year to 18 years
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965Registry updated 2026-11-04
Phase 3RecruitingTrial-stage medicine
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Where
- Brno-Sever, Hlučín, Moravska Ostrava A Privoz, Pardubice I, Prague, Prague 10, Prague 2, Uherské Hradiště, Zlín
- Age
- 18 years and over
- People
- 1,088 worldwide
- Run by
- Takeda
See details and how to joinNCT06671483EU 2024-513111-27-00Registry updated 2026-10-14
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
- Where
- Olomouc, Prague
- Age
- 5 years to 17 years
- People
- 60 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06869551EU 2024-517262-41-00Registry updated 2026-10-06
Phase 3RecruitingTrial-stage medicine
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Brno-Sever, Hlučín, Moravska Ostrava A Privoz, Pardubice I, Prague, Prague 10, Prague 2, Uherské Hradiště, Zlín
- Age
- 18 years and over
- People
- 1,182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058EU 2025-522586-30-00Registry updated 2026-09-09
Phase 3Not yet recruitingResearch participation
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (PsA)
- Where
- Břeclav, Brno-Sever, Butovice, Moravska Ostrava A Privoz, Prague, Prague 11, Prague 2, Praha 4, Praha 4-Krc, Zlín
- Age
- 18 years and over
- People
- 948 worldwide
- Run by
- MoonLake Immunotherapeutics AG
See details and how to join2025-522471-28-00EU 2025-522471-28-00Registry updated 2026-03-09
No phaseRecruitingResearch participation
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Ostrava, Pilsen
- Age
- 18 years to 75 years
- People
- 1,200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693Registry updated 2026-02-17
All Psoriatic arthritis trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.